Heterocyclic compounds as CRTH2 receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8772312
APP PUB NO 20100222270A1
SERIAL NO

12681356

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This application relates to a compound of Formula ! (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an antagonist of receptor CRTH2, as well as a process for its preparation and intermediates therefor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO LTDNO 226 THE YELLOW RIVER AVENUE SHIJIAZHUANG HEBEI PROVINCE HEBEI SHIJIAZHUANG CITY HEBEI PROVINCE 050035
CENTAURUS BIOPHARMA CO LTDBUILDING #16 TSINGHUA SCIENCE PARK YUQUAN WISDOM VALE MINZHUANG ROAD #3 HAIDIAN DISTRICT BEIJING

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Yuan, Wei W Fishers, US 2 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 8, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00